Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
KIMBERLY CLARK CORP
Kimberly-Clark announced the pricing of a $4.9 billion private offering of senior unsecured notes to fund its proposed acquisition of Kenvue. The notes are issued in five tranches with maturities ranging from 2028 to 2036, and the offering is expected to close around October 29, 2026. If the acquisition is not consummated, the company is required to redeem all outstanding notes at 101% of their aggregate principal amount.…more
KIMBERLY CLARK CORP
Kimberly-Clark announced its preliminary financial results for the third quarter of 2026, reporting net sales of $4.134 billion and an operating profit of $516 million. The company reaffirmed its previously announced full-year 2026 outlook and will release final results on November 5, 2026.…more
KIMBERLY CLARK CORP
Kimberly-Clark has secured the requisite consents for its exchange offers, which involve swapping outstanding Kenvue notes for new Kimberly-Clark notes and cash in connection with the pending acquisition of Kenvue. The consents allow for the elimination of most restrictive covenants and reporting requirements under the Kenvue indenture, with the exchange offers set to expire on October 27, 2026. The settlement is contingent upon the acquisition, which is expected to close in the fourth quarter of 2026.…more
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
China Unconditionally Approves Kimberly-Clark’s Acquisition Of Kenvue
Chinese regulators have granted unconditional approval for Kimberly-Clark's acquisition of Kenvue, clearing a major antitrust hurdle. This regulatory clearance is expected to accelerate the overall merger process between the two companies.…more
●●●●●●●● ●●●●● ●●●●●●
Kimberly-Clark is issuing $4.9 billion in senior notes across five tranches to fund its acquisition of Kenvue. This significant debt issuance to finance the acquisition may increase the company's financial leverage.…more
●●●●●●●● ●●●●● ●●●●●●
Kimberly-Clark is preparing to issue bonds to finance its upcoming acquisition of the Tylenol manufacturer. Investors should monitor the impact of this significant debt-funded purchase on the company's balance sheet.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.